Inhibitor

Bibliography

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Paper(s) concerning Lalistat-1

4 reference(s) found.
Listing paper details in reverse chronological order.
We are grateful to Keith Bradnam for improvment of this script

    Title: Off-target effects of the lysosomal acid lipase inhibitors Lalistat-1 and Lalistat-2 on neutral lipid hydrolases
    Bradic I, Kuentzel KB, Honeder S, Grabner GF, Vujic N, Zimmermann R, Birner-Gruenberger R, Kratky D
    Ref: Mol Metab, :101510, 2022 : PubMed

            

    Title: Loss of Function of Lysosomal Acid Lipase (LAL) Profoundly Impacts Osteoblastogenesis and Increases Fracture Risk in Humans
    Helderman RC, Whitney DG, Duta-Mare M, Akhmetshina A, Vujic N, Jayapalan S, Nyman JS, Misra BB, Rosen CJ and Rendina-Ruedy E <2 more author(s)>
    Ref: Bone, :115946, 2021 : PubMed

            

    Title: Human lysosomal acid lipase inhibitor lalistat impairs Mycobacterium tuberculosis growth by targeting bacterial hydrolases
    Lehmann J, Vomacka J, Esser K, Nodwell M, Kolbe K, Ramer P, Protzer U, Reiling N, Sieber SA
    Ref: Medchemcomm, 7:1797, 2016 : PubMed

            

    Title: Physiological difference in autophagic flux in macrophages from 2 mouse strains regulates cholesterol ester metabolism
    Robinet P, Ritchey B, Smith JD
    Ref: Arterioscler Thromb Vasc Biol, 33:903, 2013 : PubMed

            


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer